AB

Abbott Biotech Ventures

North America, Illinois, United States, Lake Forest

Description

Abbott Biotech Ventures makes venture capital investments in emerging biotech and pharmaceutical companies.

Investor Profile

Abbott Biotech Ventures has made 3 investments, with 0 in the past 12 months and 33% as lead.

Stage Focus

  • Series B (67%)
  • Series Unknown (33%)

Country Focus

  • United States (67%)
  • Italy (33%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Genetics
  • Life Science
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Abbott Biotech Ventures frequently co-invest with?

Sofinnova Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 1

Which angels does Abbott Biotech Ventures often collaborate with?

David R. Walt
North America, Massachusetts, United States, Boston
Shared Deals: 1
ES
North America, California, United States, Mountain View
Shared Deals: 1
PR
North America, Colorado, United States, Denver
Shared Deals: 1
Shared Deals: 1

What are some of recent deals done by Abbott Biotech Ventures?

NeuroGenetic Pharmaceuticals

Del Mar, California, United States

Neurogenetic Pharmaceuticals is engaged in the R&D of therapeutics for neurodegenerative disorders such as Alzheimer’s disease.

BiotechnologyHealth CarePharmaceutical
Series UnknownJan 4, 2012
Exicure

Chicago, Illinois, United States

Exicure is developing a new class of immunomodulatory and gene silencing drugs against validated targets.

BiotechnologyGeneticsLife ScienceTherapeutics
Series BDec 21, 2011
Amount Raised: $5,400,000
Creabilis

Samone, Emilia-Romagna, Italy

Creabilis, a specialty pharmaceutical company focused on dermatology, discovers and develops new medicines for a range of skin disorders.

BiotechnologyHealth CarePharmaceutical
Series BOct 4, 2011
Amount Raised: $20,000,000